Submit Deal

AMGEN VENTURES

Summary

Amgen Ventures is Amgen's corporate venture capital fund, dedicated to providing emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics.

Deals Overview

Total Deals13

Valued Deals13

Total Value£ 2.01 B

Avg. Deal Size£ 155 M

Market Context

Senior Management

Robert Bradway
Chairman and CEO
Philip Tagari
Vice President
Janis Naeve
Managing Director

Sort

goodwin procter

HQ - Boston

legal advisors (2)

2 Shared Deals

2 Opposite

£ 567 M

Total Value

sullivan & cromwell

HQ - New York

legal advisors (1)

1 Shared Deal

1 Opposite

£ 313 M

Total Value

guggenheim partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 Along

£ 313 M

Total Value

debevoise & plimpton

HQ - New York

legal advisors (1)

1 Shared Deal

1 Along

£ 313 M

Total Value

fenwick & west

HQ - Silicon Valley

legal advisors (1)

1 Shared Deal

1 For

£ 313 M

Total Value

bank of america

HQ - Charlotte

financial advisors (2)

2 Shared Deals

1 Along | 1 Opposite

£ 908 M

Total Value

morgan stanley

HQ - New York

financial advisors (1)

1 Shared Deal

1 Along

£ 454 M

Total Value

latham & watkins

HQ - New York, United States

legal advisors to financial advisors (1)

1 Shared Deal

1 Along

£ 454 M

Total Value

davis polk & wardwell

HQ - New York

legal advisors (1)

1 Shared Deal

1 Along

£ 454 M

Total Value

jp morgan

HQ - New York

financial advisors (2)

2 Shared Deals

1 Along | 1 Opposite

£ 690 M

Total Value

precision aq

HQ - New York

pr advisors (1)

1 Shared Deal

1 Opposite

£ 164 M

Total Value

the grace communication group

pr advisors (1)

1 Shared Deal

1 Opposite

£ 164 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy